Photo taken from: Professor Richard Scolyer / Twitter
Aug 23, 2023, 22:56
Richard Scolyer: I am super excited to now be receiving another dose of combi Immunotherapy (IO) for my glioblastoma.
Professor Richard Scolyer, CoMedical Director at Melanoma Institute Australia, Surgical Pathologist at Royal Prince Alfred Hospital, Conjoint Professor at University of Sydney, Editor of World Health Organization Skin (4th ed) and American Joint Committee on Cancer Melanoma Vice Chair (8th/9th Eds), shared the following on Twitter:
“I am super excited to now be receiving another dose of combi immunotherapy (IO) for my glioblastoma (GB). Fingers crossed incredible research data generated from my brain tumour after neoadjuvant combi IO will be translated into clinical benefit for me (& future GB patients)!”
Source: Richard Scolyer / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43